Larvol Delta - CanWell-Pharma-Announces-FDA-Clearance-of-the-IND-for-CAN016-a-DualPayload-ADC-Targeting-HER2-for-ADC-PreTreated-Solid-Tumors

CAN016 - Canwell Biotech

https://www.businesswire.com/news/home/20260401239964/en/CanWell-Pharma-Announces-FDA-Clearance-of-the-IND-for-CAN016-a-Dual-Payload-ADC-Targeting-HER2-for-ADC-Pre-Treated-Solid-Tumors

Apr 2, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next